In our study, we found that Gr1+ cells (predominantly neutrophils) isolated from diseased scaffolds and lungs at the late stage of cancer suppressed T cell proliferation in vitro while those isolated before the advanced cancer stage showed no suppression activity (Fig. S1), implying the dynamic change of Gr1+CD11b+Ly6G+ neutrophils with cancer progression. Here, ITGAM is linked to cancer.